https://orcid.org/0000-0001-9867-8861
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Katrine Risager Christensen, Casper Steenholdt, Sine Buhl, Jørn Brynskov & Mark Andrew Ainsworth. (2022) A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients’ and physicians’ preferences and adherence. Scandinavian Journal of Gastroenterology 57:3, pages 274-281.
Read now
Read now
Articles from other publishers (15)
Gisela Piñero, Míriam Mañosa, Margalida Calafat, Eva Vayreda, Fiorella Cañete, Maria Puig & Eugeni Domènech. (2023) Modificación de la dosis de mesalazina en función de los niveles de calprotectina fecal en pacientes con colitis ulcerosa en remisión clínica. Gastroenterología y Hepatología.
Crossref
Crossref
Harris A. Ahmad, James E. East, Remo Panaccione, Simon Travis, James B. Canavan, Keith Usiskin & Michael F. Byrne. (2023) Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions. Intestinal Research 21:3, pages 283-294.
Crossref
Crossref
Virginie Millet, Thomas Gensollen, Michael Maltese, Melanie Serrero, Nathalie Lesavre, Christophe Bourges, Christophe Pitaval, Sophie Cadra, Lionel Chasson, Thien Phong Vu Man, Marion Masse, Juan Jose Martinez-Garcia, Fabrice Tranchida, Laetitia Shintu, Konrad Mostert, Erick Strauss, Patricia Lepage, Mathias Chamaillard, Achille Broggi, Laurent Peyrin-Biroulet, Jean-Charles Grimaud, Philippe Naquet & Franck Galland. (2023) Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis. Gut 72:6, pages 1115-1128.
Crossref
Crossref
Qiuchan Huan, Zhengxian Gao, Peigen Wu, Yingdi Zhang, Haitao Xiao & Jiao Peng. (2023)
Picroside III, an Active Ingredient of
Picrorhiza scrophulariiflora
, Ameliorates Experimental Colitis by Protecting Intestinal Barrier Integrity
. Chemistry & Biodiversity 20:6.
Crossref
Crossref
Bella Ungar, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Rami Eliakim, Dror Shouval, Yishai Levin, Alon Savidor, Shani Ben-Moshe, Rita Manco, Stav Dan, Adi Egozi, Keren Bahar Halpern, Chen Mayer, Iris Barshack, Shomron Ben-Horin & Shalev Itzkovitz. (2022) Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Gut 71:10, pages 1988-1997.
Crossref
Crossref
S Giri, S Angadi & R Jadhav. (2022) Stopping rules for 5‐ASA in UC need to be redefined. Journal of Gastroenterology and Hepatology 37:7, pages 1404-1404.
Crossref
Crossref
Charlotte Keung, Philip Heraud, Nathan Kuk, Rebecca Lim, William Sievert, Gregory Moore & Bayden Wood. (2022) Fourier-Transform Infra-Red Microspectroscopy Can Accurately Diagnose Colitis and Assess Severity of Inflammation. International Journal of Molecular Sciences 23:5, pages 2849.
Crossref
Crossref
Edoardo Vespa, Ferdinando D’Amico, Mauro Sollai, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Arianna Dal Buono, Roberto Gabbiadini, Silvio Danese & Gionata Fiorino. (2022) Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art. Journal of Clinical Medicine 11:4, pages 939.
Crossref
Crossref
Irit Avni-Biron, Ariella Bar-Gil Shitrit, Benjamin Koslowsky, Asaf Levartovsky, Uri Kopylov, Roni Weisshof, Nathaniel Aviv Cohen, Nitsan Maharshak, David Hovel, Eran Israeli, Timna Naftali, Idan Goren, Yfat Snir, Jacob E. Ollech, Hagar Banai-Eran, Yelena Broitman, Tali Sharar-Fischler, Iris Dotan & Henit Yanai. (2022) Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel. Digestive and Liver Disease 54:2, pages 192-197.
Crossref
Crossref
Gonzalo Hijos-Mallada, Raul Velamazán, Raúl Marti, Eduardo Chueca, Samantha Arechavaleta, Alberto Lué, Fernando Gomollón, Angel Lanas & Carlos Sostres. (2021) A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients. Diagnostics 11:12, pages 2323.
Crossref
Crossref
Jacob T. Bjerrum, Yulan L. Wang, Jakob B. Seidelin & Ole H. Nielsen. (2021) IBD metabonomics predicts phenotype, disease course, and treatment response. eBioMedicine 71, pages 103551.
Crossref
Crossref
Lifen Wang, Jiawei Xu, Pengpeng Xue, Jiayi Liu, Lanzi Luo, Deli Zhuge, Qing Yao, Xiaokun Li, Yingzheng Zhao & Helin Xu. (2021) Thermo-sensitive hydrogel with mussel-inspired adhesion enhanced the non-fibrotic repair effect of EGF on colonic mucosa barrier of TNBS-induced ulcerative colitis rats through macrophage polarizing. Chemical Engineering Journal 416, pages 129221.
Crossref
Crossref
Elisabeth Schnoy, Helmut Messmann & Ralf Kiesslich. (2021) Überwachung und Management von Dysplasien bei chronisch-entzündlichen DarmerkrankungenSurveillance and management of dysplastic lesions in patients with inflammatory bowel disease. Der Gastroenterologe 16:4, pages 267-277.
Crossref
Crossref
Gionata Fiorino, Silvio Danese, Giovanni Giacobazzi & Antonino Spinelli. (2021) Medical therapy versus surgery in moderate-to-severe ulcerative colitis. Digestive and Liver Disease 53:4, pages 403-408.
Crossref
Crossref
Virginia Solitano, Ferdinando D’Amico, Eirini Zacharopoulou, Laurent Peyrin-Biroulet & Silvio Danese. (2020) Early Intervention in Ulcerative Colitis: Ready for Prime Time?. Journal of Clinical Medicine 9:8, pages 2646.
Crossref
Crossref